{
    "id": "74c3457e-079c-4b2b-bae4-3f148540a27a",
    "indications": {
        "text": "pramipexole dihydrochloride extended- release tablet non-ergot dopamine agonist indicated treatment parkinson 's disease ( pd ) ( 1 )",
        "doid_entities": [
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "pramipexole dihydrochloride extended- release tablets taken daily , without food ( 2.1 ) tablets must swallowed whole must chewed , crushed , divided ( 2.1 ) starting dose 0.375 mg given daily ( 2.2 ) dose may increased gradually , frequently every 5 7 days , first 0.75 mg per day 0.75 mg increments maximum recommended dose 4.5 mg per day . assess therapeutic response tolerability minimal interval 5 days longer dose increment ( 2.2 ) patients may switched overnight immediate-release pramipexole tablets pramipexole dihydrochloride extended- release tablets daily dose . dose adjustment may needed patients ( 2.3 ) pramipexole dihydrochloride extended- release tablets discontinued gradually ( 2.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "pramipexole dihydrochloride extended- release tablets available follows : 0.375 mg : white off-white , round , biconvex tablets debossed `` 0.375 `` one side `` p11 `` side . unit bottles 30 ndc 50742-331-30 0.75 mg : white off-white , round , biconvex tablets debossed `` 0.75 `` one side `` p12 `` side . unit bottles 30 ndc 50742-332-30 1.5 mg : white off-white , oval , biconvex tablets debossed `` 1.5 `` one side `` p13 `` side . unit bottles 30 ndc 50742-333-30 2.25 mg : white off-white , oval , biconvex tablets debossed `` 2.25 `` one side `` p14 `` side . unit bottles 30 ndc 50742-334-30 3 mg : white off-white , oval , biconvex tablets debossed `` 3.0 `` one side `` p15 `` side . unit bottles 30 ndc 50742-335-30 3.75 mg : white off-white , oval , biconvex tablets debossed `` 3.75 `` one side `` p16 `` side . unit bottles 30 ndc 50742-336-30 4.5 mg : white off-white , oval , biconvex tablets debossed `` 4.5 `` one side `` p17 `` side . unit bottles 30 ndc 50742-337-30",
    "adverseReactions": "none .",
    "ingredients": [
        {
            "name": "PRAMIPEXOLE DIHYDROCHLORIDE",
            "code": "3D867NP06J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_8356"
        },
        {
            "name": "HYPROMELLOSE 2208 (15000 MPA.S)",
            "code": "Z78RG6M2N2",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "SODIUM METABISULFITE",
            "code": "4VON5FNS3C",
            "drugbank_id": "https://go.drugbank.com/drugs/DB15842"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        }
    ],
    "organization": "Ingenus Pharmaceuticals, LLC",
    "name": "Pramipexole dihydrochloride",
    "effectiveTime": "20250424",
    "indications_original": "Pramipexole dihydrochloride extended- release tablet is a non-ergot dopamine agonist indicated for the treatment of Parkinson's disease (PD) ( 1 )",
    "contraindications_original": "Pramipexole dihydrochloride extended- release tablets are taken once daily, with or without food ( 2.1 ) Tablets must be swallowed whole and must not be chewed, crushed, or divided ( 2.1 ) Starting dose is 0.375 mg given once daily ( 2.2 ) Dose may be increased gradually, not more frequently than every 5 to 7 days, first to 0.75 mg per day and then by 0.75 mg increments up to a maximum recommended dose of 4.5 mg per day. Assess therapeutic response and tolerability at a minimal interval of 5 days or longer after each dose increment ( 2.2 ) Patients may be switched overnight from immediate-release pramipexole tablets to pramipexole dihydrochloride extended- release tablets at the same daily dose. Dose adjustment may be needed in some patients ( 2.3 ) Pramipexole dihydrochloride extended- release tablets should be discontinued gradually ( 2.2 )",
    "warningsAndPrecautions_original": "Pramipexole dihydrochloride extended- release tablets are available as follows:\n                        0.375 mg: white or off-white, round, biconvex tablets debossed \"0.375\" on one side and \"P11\" on the other side.\n                        Unit of Use Bottles of 30\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 50742-331-30\n                        0.75 mg: white or off-white, round, biconvex tablets debossed \"0.75\" on one side and \"P12\" on the other side.\n                        Unit of Use Bottles of 30\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 50742-332-30\n                        1.5 mg: white or off-white, oval, biconvex tablets debossed \"1.5\" on one side and \"P13\" on the other side.\n                        Unit of Use Bottles of 30\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 50742-333-30\n                        2.25 mg: white or off-white, oval, biconvex tablets debossed \"2.25\" on one side and \"P14\" on the other side.\n                        Unit of Use Bottles of 30\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 50742-334-30\n                        3 mg: white or off-white, oval, biconvex tablets debossed \"3.0\" on one side and \"P15\" on the other side.\n                        Unit of Use Bottles of 30\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 50742-335-30\n                        3.75 mg: white or off-white, oval, biconvex tablets debossed \"3.75\" on one side and \"P16\" on the other side.\n                        Unit of Use Bottles of 30\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 50742-336-30\n                        4.5 mg: white or off-white, oval, biconvex tablets debossed \"4.5\" on one side and \"P17\" on the other side.\n                        Unit of Use Bottles of 30\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 50742-337-30",
    "adverseReactions_original": "None.",
    "drug": [
        {
            "name": "Pramipexole dihydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_8356"
        }
    ]
}